News Room
Adcock Ingram reports muted results
2025/02/20 08:59:18Johannesburg – The Adcock Ingram Group’s financial and operational performance ended below expectations, driven by several sector-specific factors, including constrained consumer spending within the lower LSMs and reduced inventory holdings in the pharmaceutical wholesale channel.
[READ MORE]
Adcock Ingram delivers healthy financial results
2024/08/22 10:57:50Johannesburg – The Adcock Ingram Group is pleased to report a 10% increase in headline earnings per share for the year ended 30 June 2024.
[READ MORE]
Adcock Ingram reports a resilient trading performance in a difficult market for the six-months ended 31 December 2023
2024/02/22 00:00:00Johannesburg – The Adcock Ingram Group today reported an increase in turnover of 1% for the six-month period to 31 December 2023. Turnover grew in the Consumer and Hospital divisions, but was flat in the Prescription and Over-The-Counter divisions. This trading performance was achieved in a constrained environment where consumers remain under pressure from high interest rates, exchange rate depreciation, high inflation and continued loadshedding, all of which result in lower disposable income.
[READ MORE]
Adcock Ingram delivers healthy financial results
2023/08/23 09:04:45Johannesburg – The Adcock Ingram Group is pleased to report a 12% increase in headline earnings per share for the year ended 30 June 2023, in a challenging economic environment, characterised by currency weakness and volatility, poor economic growth and increasing pressure on consumer disposable income.
[READ MORE]
Adcock Ingram reports a healthy financial and operational performance for the six-months ended 31 December 2022
2023/02/22 09:39:56Johannesburg – The Adcock Ingram Group today reported an increase in turnover of 8%, with trading profit growth of 15%, for the six-month period ended 31 December 2022, attributed to its diverse and affordable portfolio of products, well-executed sales and marketing strategies, and a continued focus on customer service.
[READ MORE]
The Adcock Ingram Group reports an exceptional set of results for the year ended 30 June 2022
2022/08/25 07:21:32Johannesburg – The Adcock Ingram Group delivered an exceptional operational and financial performance for the year ended 30 June 2022. The Group reported a 12% increase in turnover, driven by the increase in demand for over-the-counter (OTC), and consumer healthcare products, following the lower and subsequent lifting of the lock-down levels, required during the COVID-19 pandemic.
[READ MORE]
Adcock Ingram reports strong operational and financial performance for the six months to 31 December 2021
2022/02/23 07:27:12Johannesburg – Adcock Ingram today reported an increase in turnover of 16%, an exceptional increase of 25% in trading profit, and excellent cash generation for the first half of the financial year to 31 December 2021, driven mainly by improved demand for its over-the-counter (OTC) and consumer healthcare products.
[READ MORE]
Adcock Ingram reports resilient performance under COVID-19
2021/08/25 00:00:00Johannesburg – The Adcock Ingram Group delivered a healthy set of results in the year ended 30 June 2021, with turnover increasing by 6%, despite the effects of the COVID-19 pandemic.
[READ MORE]
The Adcock Ingram Group reports a resilient trading performance for the six-months ended 31 December 2020
2021/02/24 07:17:11Johannesburg – The Adcock Ingram Group today reported a 4% increase in turnover for the six-month period to 31 December 2020. The Group achieved these sales in challenging trading conditions brought about by COVID-19, in a depressed economy, and declines in demand for certain categories of medicine and products.
[READ MORE]
Adcock Ingram reports satisfying results
2020/08/26 07:11:23Johannesburg – The Adcock Ingram Group is pleased to report a 4% increase in turnover for the year ended 30 June 2020. The Group achieved these results despite the challenging conditions such as the general economic downturn, significant cost-push due to Rand weakness, global supply chain disruptions, and declines in demand for certain categories of medicine and products.
[READ MORE]
Adcock Ingram Critical Care completes precautionary COVID-19 testing of primary contact employees
2020/04/28 08:38:13Midrand – On Thursday, 23 April, an employee at the Aeroton facility tested positive for COVID-19, and as a precaution, 57 employees from a specific operating department were referred to a private pathology laboratory for testing on the same day, and were self-quarantined based on the primary contact trace in line with the company’s COVID-19 protocols.
[READ MORE]
Adcock Ingram employee has tested positive for COVID-19
2020/04/24 08:41:43Midrand – An employee in the Adcock Ingram Critical Care manufacturing facility has tested positive for COVID-19, and 50 other employees have undergone testing today, and self-quarantined based on the primary contact trace.
[READ MORE]